Malignant mesothelioma pleural rate survival

Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. A study by Purohit et al has shown that weekly systemic administration of cisplatin and interferon a2a in diffuse malignant pleural mesothelioma. Recombinant human interferon alpha given intrapleurally has resulted in 2 partial responses among 13 patients with pleural mesothelioma. Biological therapies in malignant mesothelioma In mouse model experiments with mesothelioma human recombinant interferon alpha suggests that this effect may be true in humans as well. Methotrexate with rescue, 5-azacytidine, and 5-flurouracil may have single agent activity against mesothelioma. Response rates vary widely in different series of reports.

Doxorubicin appears to have some activity against mesothelioma. Single agent chemotherapy drugs for mesothelioma There are several chemotherapeutic agents that may be active in the treatment of mesothelioma. If you still cannot find the page you were interested in, please send us feedback. The page you requested was not found In 15 seconds you will be automatically transferred to the home page...

Forgot your username or password. There is little general consensus with regard to treatment modalities and the role of clinical staging in the management of diffuse malignant mesothelioma of the pleura. Current treatment strategies for malignant mesothelioma vary according to the referral centre, and include combinations of surgery, radiotherapy, chemotherapy, immunotherapy, photodynamic therapy and medical palliation. It has previously been demonstrated that age, duration of symptoms, degree of thrombocytosis and histological subtype have prognostic implications for malignant mesothelioma.

TNM system, in line with other forms of malignancy, and updated in 1995 by the International Mesothelioma Interest Group. The original staging system devised by Butchart et al. Histological subtypes include epithelioid , sarcomatous and biphasic. Diagnosis relies on histological analysis of adequate pleural biopsies. The incidence of the disease continues to rise in the UK where annual male mesothelioma deaths are expected to reach about 3000 by the year 2020. The disease shows a male preponderance, with presentation between the fifth and the seventh decades. The simian virus 40 was recently identified as a significant additional carcinogen. Recognition of an association between asbestos exposure and malignant mesothelioma dates from the work of Wagner and colleagues in the 1960s.

It arises from the mesothelial surfaces of the pleura as well as the peritoneum and the pericardium. Sometimes doctors refer to this disease as mesothelioma of the pleura. Pleural mesothelioma is a disease that affects the lining of the lungs, or lung pleura.